What's breaking now, across thousands of outlets.
(RTTNews) - Eli Lilly and Co. (LLY) announced on Monday that it has agreed to acquire Merida Biosciences, a biotechnology company developing precision therapeutics for autoimmune and allergic diseases, in a transaction valued at up to $2.875 billion.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The company's net profit from January to June was 23.8 billion yuan (US$3.54 billion), down from 37.2 billion yuan during the same period in 2025.
The company's net profit from January to June was 23.8 billion yuan (US$3.54 billion), down from 37.2 billion yuan during the same period in 2025.
A former top European Union official has struck a bullish tone on the outlook for China-EU trade talks, saying he expects progress in the coming months.
(RTTNews) - CollPlant Biotechnologies Ltd. (CLGN) announced Monday that it has signed a definitive agreement to acquire Israeli deep-tech company LightSolver Ltd.
Alpaca reaches 14 million brokerage accounts across more than 300 financial institutions worldwide, giving Kalshi a path to international expansion
Key PointsVanguard Morningstar Mega Cap Growth ETF and Vanguard Morningstar Small-Cap Growth ETF both feature a low 0.05% expense ratio.
